Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
002898 Sailong Pharmaceutical Group
- 6.26
- +0.29+4.86%
Market Closed Apr 30 15:00 CST
1.10BMarket Cap-30.84P/E (TTM)
6.27High5.93Low99.44KlotVolume5.93Open5.97Pre Close61.04MTurnover9.82%Turnover RatioLossP/E (Static)176.00MShares12.3952wk High2.21P/B633.90MFloat Cap5.7752wk Low6.27Limit Up101.26MShs Float30.73Historical High5.67Limit Down5.70%Amplitude5.77Historical Low0.02Dividend TTM6.14Avg Price48.55KlotAsk0.32%Div YieldTTM100Lot Size50.03KlotBid
Sailong Pharmaceutical Group News
Sailong Pharmaceutical: Announcement on the receipt of a warning letter from the Guangdong Securities Regulatory Bureau by the Company and related personnel
Sailong Pharmaceutical: 2024 Independent Director Debriefing Report (Chen Xiaoxin)
Cailong Pharmaceutical: Announcement of Supervisory Board Resolutions
Cailong Pharmaceutical: Internal Control Self-Assessment Report
Cailong Pharmaceuticals: Internal Control Audit Report
Cailong Pharmaceuticals: 2024 Annual Audit Report
Cailong Pharmaceutical: Report on the work of the Supervisory Committee in 2024
Sailong Pharmaceutical: 2024 Independent Director Debriefing Report (Li Gongfen)
Cailong Pharmaceutical: Announcement of Board Resolutions
Cailong Pharmaceutical: Special opinion of the board of directors on the evaluation of the independence of independent directors
Sailong Pharmaceutical: Annual Special Audit Report on Related Party Capital Occupation
Cailong Pharmaceutical: 2024 Board Work Report
Cailong Pharmaceutical: Special Verification Report on the Operating Income Deduction Status Table
Sailong Pharmaceutical: 2024 Independent Director Debriefing Report (Pan Chuanyun)
Sailong Pharmaceutical: Review Opinions of the Fourth Board of Directors of the Independent Directors Meeting in 2025
Sailong Pharmaceutical: Announcement of Resolutions of the 7th Meeting of the 4th Supervisory Committee
Sailong Pharmaceutical: “Public Opinion Management System”
Sailong Pharmaceutical: Announcement on the company\'s application for credit from the bank and the actual controller providing a guarantee
Sailong Pharmaceutical: Announcement of Resolutions of the 7th Meeting of the Fourth Board of Directors
Sailong Pharmaceutical: Announcement on changing the signed certified public accountant
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts